Changes in the plasma levels of PGE, PGF2 alpha and 6-keto-PGF1 alpha in canine endotoxic shock.
D015121:6-Ketoprostaglandin F1 alpha / Q000097:blood*; D000293:Adolescent; D000818:Animals; D002648:Child; D002675:Child, Preschool; D015237:Dinoprost; D004285:Dogs; D011464:Epoprostenol / Q000097:blood; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D011458:Prostaglandins E / Q000097:blood*; D011460:Prostaglandins F / Q000097:blood*; D012772:Shock, Septic / Q000097:blood* / Q000188:drug therapy; D012991:Solanaceous Alkaloids / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D011458:Prostaglandins E; D011460:Prostaglandins F; D012991:Solanaceous Alkaloids; D014665:Vasodilator Agents; C003922:anisodamine; D015121:6-Ketoprostaglandin F1 alpha; D015237:Dinoprost; D011464:Epoprostenol